HOUSTON REYNOLDS: Open Payments
NPI 1609498336 · MONTPELIER, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$170 in 7 payments from 6 companies in 2025. Trend: 2023 $46 · 2024 $248 · 2025 $170
Food & beverage: $170
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 2 | $43 |
| Astellas Pharma US Inc | 1 | $32 |
| Exact Sciences Corporation | 1 | $27 |
| Supernus Pharmaceuticals, Inc. | 1 | $26 |
| Reprise Biomedical, Inc. | 1 | $24 |
| Novo Nordisk Inc | 1 | $18 |
Products named: QULIPTA, Veozah, Cologuard Collection Kit, Qelbree, Miro3D, Ozempic.
Industry payments across ID — which companies pay providers there.
